Complete response (n = 9) | Partial response (n = 10) | ||
---|---|---|---|
BF [ml/100ml/min] | 36.3 ± 23.2 | 51 ± 31.6 | 0.271 |
BV[ml/100ml] | 11.6 ± 5 | 14.4 ± 4.8 | 0.240 |
TTP [s] | 26.3 ± 8.3 | 24 ± 7.8 | 0.551 |
PMB [ml/100ml/min] | 37.3 ± 19.3 | 33.6 ± 10.9 | 0.616 |
ALP [ml/100ml/min] | 38.7 ± 22.2 | 49 ± 28.9 | 0.400 |
PVP [ml/100ml/min] | 20.8 ± 22.7 | 13 ± 17 | 0.404 |
HPI [%] | 65.1 ± 30.7 | 78.6 ± 27.4 | 0.322 |
Threshold value | Group 1 mean survival [months] | Group 2 mean survival [months] | ||
---|---|---|---|---|
BF | 50.4 ml/100ml/min | 35.6 ± 5 | 18.8 ± 2.7 | 0.033 |
BV | 13.3 ml/100ml | 35.2 ± 4.3 | 18.8 ± 4.1 | 0.028 |
TTP | 19 s | 16.4 ± 0.8 | 33.2 ± 4.7 | 0.015 |
PMB | 40.2 ml/100ml/min | 33.8 ± 4.2 | 15.9 ± 5.4 | 0.079 |
ALP | 33.1 ml/100ml/min | 30.2 ± 6.6 | 27.1 ± 3.8 | 0.691 |
PVP | 1.8 ml/100ml/min | 23.5 ± 5.5 | 30.8 ± 4.7 | 0.400 |
HPI | 82.7 % | 32.8 ± 6 | 24 ± 3.8 | 0.244 |
Age [years] | 68.8 ± 5.8 |
---|---|
Sex (M/F), n [%] | 17/1 [94.4/5.6] |
Cirrhosis (yes/no), n [%] | 16/2 [88.9/11.1] |
Aetiology of cirrhosis, n [%] | |
Alcohol | 7 [43.8] |
HBV | 3 [18.8] |
HCV | 1 [6.3] |
Other | 5 [31.3] |
Albumin [g/l] | 38.3 ± 5.1 |
INR | 1.2 ± 0.3 |
Total bilirubin [mmol/l] | 23.6 ± 18.8 |
Child-Pugh score (points) | 5.7 ± 0.8 |
A, n [%] | 14 [77.8] |
B, n [%] | 4 [22.2] |
Creatinine [µmol/l] | 87.8 ± 22.8 |
AST [µkat/l] | 1.1 ± 0.9 |
ALT [µkat/l] | 0.9 ± 0.8 |
γGT [µkat/l] | 1.9 ± 1.1 |
AFP [kIE/l] | 174.5 ± 279.3 |
Portal vein thrombosis (yes/no), n [%] | 3/15 [16.7/83.3] |
Bilobar disease, n [%] | 4 [22.2] |
Unilobar disease, n [%] | 14 [77.8] |
Right lobe, n [%] | 13 [92.9] |
Left lobe, n [%] | 1 [7.1] |
Overall number of lesions, n | 56 |
Average number of nodules per patient | 3.1 ± 2.1 |
Average of HCC nodule diameters [cm] | 4.4 ± 1.8 |